FDA Inspection
Sanofi Winthrop IndustrieSanofi Winthrop Industrie – FDA Inspection, Jan 26, 2024
Record Details
This FDA Inspection record concerns Sanofi Winthrop Industrie, with an inspection on January 26, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 3de20bb5-b52b-4167-be9a-6f65dcbd7be9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1227792
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
FDA Citations
4- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sanofi Winthrop Industrie
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 17, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 18, 2020 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 13, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 28, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Sanofi Winthrop Industrie
- FDA Inspection 1223859 - 2023-11-17
- FDA Inspection 1120933 - 2020-02-18
- FDA Inspection 1059004 - 2018-07-13
- FDA Inspection 994790 - 2016-07-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.